ESMO Advanced Course on NTRK Gene Fusion - A New Target in Precision Treatment of Cancer

Learning Objectives

• Acquire knowledge of the TRK Family members and their roles in ontogenesis
• Understand the mechanisms of gene fusion and the different fusion partners involved
• Learn how TRK receptors are structured and how their activation impacts signal transduction
• Review the epidemiology of NTRK gene fusion in human tumours
• Understand the methodology to identify NTRK gene fusion and the challenges of testing
• Update your knowledge on the present outcome obtained with NTRK inhibitors, their toxicities and clinical management

Download the programme

Accreditation

The programme of this event will be accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

• Jean-Yves Blay, France
• Frédérique Penault-Llorca, France